A Paris-based biotechnology company that generates and characterises novel molecular data from microbial genomes to support drug discovery and expand the chemical space available for developing new medicines.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €20 M | Apr, 2026 | series-a |
Industries
Frequently Asked Questions
Where is Generare located?
Generare is located in Paris, France.
What industries does Generare operate in?
Generare operates in the following industries: biotechnology, drug discovery, molecular data, life sciences.
When was Generare founded?
Generare was founded on 2026-04-03.
How much total funding has Generare raised?
Generare has raised a total of $20,000,000.
Who are the investors in Generare?
The investors in Generare are: Daphni, Alven.
Who are the founders of Generare?
The founders of Generare are: Guillaume Vandenesch, Dr. Vincent Libis.
What is Generare?
Generare (officially Generare Bioscience) is a French biotechnology company based in Paris that focuses on drug discovery. The company uses a data-driven platform that combines synthetic biology, DNA sequencing, and computational tools to uncover bioactive molecules, known as natural products, from microbial genomes.
Who founded Generare and where are they based?
Generare was founded in 2023 by Guillaume Vandenesch (CEO) and Dr. Vincent Libis (CSO). The company is headquartered at 4 Rue Maillard, 75011 Paris, France.
What is the function of the Generare "discovery factory"?
The Generare "discovery factory" is an industrial-scale platform designed to accelerate the identification of novel bioactive molecules. It utilizes a shotgun cloning technique to break down thousands of microbial genomes into random fragments, which are then expressed and analyzed in parallel. This process allows the company to efficiently screen and uncover natural products that were previously inaccessible, serving as starting points for new therapeutic treatments.